Related Experiment Videos
Studies on human plasma alpha 2-macroglobulin-enzyme interactions. Evidence for proteolytic modification of the
Abstract:
Human plasma alpha(2)-macroglobulin is an inhibitor of circulating proteases that function in hemostatic and inflammatory reactions but the biochemical nature of its interaction with these enzymes is not well defined. This investigation has found that alpha(2)-macroglobulin is comprised of subunit chains of 185,000 molecular weight as analyzed by electrophoresis in polyacrylamide gels containing sodium dodecyl sulfate. Trypsin, thrombin, plasmin, and plasma kallikrein in amounts completely bound to alpha(2)-macroglobulin attacked one region in the subunit chain producing a single derivative with a molecular weight of 85,000 indicating that hydrolysis occurred at or near the center of the parent chain. The proteolytic derivative was also identified in an alpha(2)-macroglobulin preparation from plasma incubated with the plasminogen activator, urokinase. alpha(2)-macroglobulin functionally capable of binding enzyme appeared to be required both for limiting tryptic hydrolysis and for confining the concentration dependent increase in the derivative chain to the 1st min of incubation since acid-denatured alpha(2)-macroglobulin that failed to bind trypsin was extensively degraded. Three derivative chains resulted from the interaction of alpha(2)-macroglobulin with chymotrypsin demonstrating the presence of at least two chymotrypsin susceptible regions in the precursor chain. Reduction of the alpha(2)-macroglobulin-enzyme mixture was required for the identification of the derivative subunit chains establishing that these cleavage products were covalently linked to the parent molecule by disulfide bridges. Thus, alpha(2)-inacroglobulin acts as a substrate for circulating proteases, a finding which may also pertain to the mechanism of action of other plasma enzyme inhibitors.
Insights
Human alpha(2)-macroglobulin, a protease inhibitor, acts as a substrate for proteases like trypsin and thrombin. This interaction cleaves its subunit chains, revealing insights into enzyme inhibition mechanisms.
Area of Science:
- Biochemistry
- Molecular Biology
- Proteomics
Background:
- Human alpha(2)-macroglobulin is a key plasma protease inhibitor involved in hemostasis and inflammation.
- The precise biochemical mechanism of its interaction with proteases remains incompletely understood.
Purpose of the Study:
- To elucidate the biochemical nature of the interaction between human alpha(2)-macroglobulin and various proteases.
- To characterize the structural changes in alpha(2)-macroglobulin upon protease binding and hydrolysis.
Main Methods:
- Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) to analyze subunit molecular weights.
- Incubation of alpha(2)-macroglobulin with specific proteases (trypsin, thrombin, plasmin, plasma kallikrein, chymotrypsin) and analysis of resulting derivatives.
- Use of urokinase to generate plasminogen activator and subsequent analysis.
Main Results:
- Alpha(2)-macroglobulin consists of 185,000 MW subunit chains.
- Proteases like trypsin and thrombin cleave the subunit chain at a central region, yielding an 85,000 MW derivative.
- Functional alpha(2)-macroglobulin limits hydrolysis, while denatured forms are degraded; chymotrypsin generates three derivative chains, indicating multiple cleavage sites.
- Disulfide bridges link the derivative chains to the parent molecule.
Conclusions:
- Human alpha(2)-macroglobulin functions as a substrate for circulating proteases, not just an inhibitor.
- Protease hydrolysis of alpha(2)-macroglobulin subunit chains is a key event in its mechanism of action.
- This substrate-like behavior may be relevant to the function of other plasma enzyme inhibitors.